In March, the market continued to fluctuate and the annual reports were disclosed one after another. Institutional investors are actively participating in research and further communicating with listed companies on performance.
Specifically, the biomedical track has experienced a long-term valuation adjustment and is still the focus of institutions. Recently, Xie Zhiyu, Qiao Qian, Tong LAN of Xingzheng Global Fund and Chen Sen of Anxin fund appeared at the Apeloa Pharmaceutical Co.Ltd(000739) research meeting.
Thunder Software Technology Co.Ltd(300496) ‘s performance presentation also attracted the attention of more than 100 institutions, including Yang Yu of huitianfu fund, GUI Kai of Harvest Fund and Guo Xiaowen of China Post Fund. By the end of last year, the eight funds under Kai’s management had all held positions in the company.
China National Gold Group Gold Jewellery Co.Ltd(600916) held more than ten investor research meetings in February, when the market risk aversion was heating up, and Cao Mingchang of China Europe Fund also appeared in the company’s research meeting for the first time. The public offering institution is not the main investor of China National Gold Group Gold Jewellery Co.Ltd(600916) and Mr. Cao’s first public research since this year deserves attention.
Xie Zhiyu, Chi chensen and other positions Apeloa Pharmaceutical Co.Ltd(000739)
on March 9, Apeloa Pharmaceutical Co.Ltd(000739) held a video conference with the participation of 215 investment institutions, including head public offering such as e fund, Xingzheng global, gf and Boshi, China Life Insurance Company Limited(601628) endowment insurance and other insurance funds, as well as head foreign investment such as GSAM and PAG investment
It is worth noting that Xie Zhiyu, Qiao Qian and Tong LAN of Xingzheng Global Fund attended the meeting. Chi chensen, a cutting-edge pharmaceutical fund manager who has attracted much attention from the industry recently, is also on the list of participants.
Apeloa Pharmaceutical Co.Ltd(000739) is a large comprehensive pharmaceutical enterprise integrating research, development and production of APIs, preparations and pharmaceutical intermediates. According to the company’s latest 2021 annual report, the company achieved an annual operating revenue of 8.943 billion yuan, a year-on-year increase of 13.49%. The company achieved a year-on-year growth rate of RMB 1.394 billion in a number of businesses, of which the company achieved a year-on-year growth rate of RMB 1.394 billion.
Xie Zhiyu’s two funds have heavy positions Apeloa Pharmaceutical Co.Ltd(000739) . By the end of 2021, Xie Zhiyu’s Xingquan Herun held Apeloa Pharmaceutical Co.Ltd(000739) 29267100 shares, and Apeloa Pharmaceutical Co.Ltd(000739) was the tenth largest heavy position stock of the fund, accounting for 3.07%; Xie Zhiyu’s other fund, Xingquan Heyi, holds 203689 million shares of Purun pharmaceutical. Meanwhile, Apeloa Pharmaceutical Co.Ltd(000739) ‘s annual report shows that Xingquan Herun and Xingquan Heyi are the fifth and eighth largest shareholders of the company respectively.
Chi chensen is the rising star of this year’s medical track. By the end of 2021, Apeloa Pharmaceutical Co.Ltd(000739) was the fourth largest heavy position stock of Anxin medical health under his management.
Anxin medical health was founded in January 2021, with a total return of about 30% in the last year. According to the disclosure of the annual report, there is no obvious “style drift” phenomenon in the fund, and the investment scope is still locked in the listed companies of the pharmaceutical and biological track. In the context of the poor overall performance of the pharmaceutical sector and the negative performance of most pharmaceutical theme funds in the last year, the performance of this fund is indeed very outstanding.
Chi chensen has been a fund manager for more than one year and has attracted great attention from the industry. Insiders commented that Chi chensen has a high sensitivity to market changes, flexible position adjustment, and a thorough understanding of various segments of the pharmaceutical industry.
Yang Ying, GUI Kai and others paid attention to Thunder Software Technology Co.Ltd(300496)
Thunder Software Technology Co.Ltd(300496) held two intensive performance presentations on March 4 and March 8, attracting the participation of 510 and 353 institutions respectively
The participating institutions include huitianfu, Fuguo, harvest and other head public offerings, China Life Insurance Company Limited(601628) insurance and other insurance capital, and Schroders investment and other head foreign capital.
It is worth noting that the on-site meeting on Thunder Software Technology Co.Ltd(300496) 3 / 4 attracted the participation of Yang Yu of huitianfu fund, GUI Kai of Harvest Fund and Guo Xiaowen of CNPC fund, and Yang Yu reappeared in the video conference on March 8.
Thunder Software Technology Co.Ltd(300496) is a leading provider of intelligent platform technology. According to the annual report of 2021, the company achieved an annual operating revenue of 4.127 billion yuan, a year-on-year increase of 57.04%. The revenue of the three major businesses, intelligent software, intelligent connected vehicle and intelligent Internet of things, increased by 40.33%, 58.91% and 82.87% respectively year-on-year.
In terms of institutional positions, by the end of 2021, Harvest Fund’s 14 products held Thunder Software Technology Co.Ltd(300496) , accounting for 6.81% of the outstanding shares. Among them, all 8 funds under Kai’s management hold Thunder Software Technology Co.Ltd(300496) shares. Harvest emerging industry, harvest core growth and harvest vision selection are the seventh, eighth and tenth largest shareholders of Thunder Software Technology Co.Ltd(300496) respectively.
Guoxiaowen also holds Thunder Software Technology Co.Ltd(300496) , but the number of shares is small. Yang Yu has no position for the time being.
Recently, Thunder Software Technology Co.Ltd(300496) issued a new fixed growth plan, which is expected to raise no more than 3.1 billion yuan. At this performance presentation meeting, investors focused on the refinancing and the improvement of the profitability of the Internet of things business.
In response, Thunder Software Technology Co.Ltd(300496) responded that the company will focus on layout and focus on several key areas, including edge computing, distributed computing, etc. With the increase of shipments, gross profit margin and cash flow will improve.
Cao Mingchang research China National Gold Group Gold Jewellery Co.Ltd(600916)
China National Gold Group Gold Jewellery Co.Ltd(600916) the video research conference held on March 1 attracted the participation of 17 institutions, including well-known institutional investors such as Ruiyuan fund
China National Gold Group Gold Jewellery Co.Ltd(600916) is a well-known central enterprise in the field of China National Gold Group Gold Jewellery Co.Ltd(600916) jewelry sales. It is a large comprehensive mining company integrating geological exploration, mining, processing and sales, scientific research and development, and has a complete upstream and downstream industrial chain.
Recently, affected by the change of geopolitical situation, the market risk aversion has increased. China National Gold Group Gold Jewellery Co.Ltd(600916) since late January this year, the stock price has fluctuated greatly. Since February, China National Gold Group Gold Jewellery Co.Ltd(600916) has intensively held more than ten research meetings. Among them, the on-site meeting held on February 22 attracted the participation of Cao Mingchang of China EU fund.
In terms of institutional positions, public funds have never been the main investors of China National Gold Group Gold Jewellery Co.Ltd(600916) and Mr. Cao does not hold shares of the company at present. This is his first investigation of the company.
It is worth noting that the frequency of Cao Mingchang’s participation in the research of listed companies is not high. Throughout 2021, Cao Mingchang only had public research records in a few listed companies, such as Guangdong Yizumi Precision Machinery Co.Ltd(300415) , Ocean’S King Lighting Science & Technology Co.Ltd(002724) , Lianhe Chemical Technology Co.Ltd(002250) , Dongguan Yutong Optical Technology Co.Ltd(300790) , etc. China National Gold Group Gold Jewellery Co.Ltd(600916) is the first company with research records since Cao Mingchang this year.
